dpp4 and glp 1 combination Frontiers Insights into the Roles of

References Wegovy (semaglutide) Prescribing Information Novo Nordisk FDA Drug Label Zepbound (tirzepatide) Prescribing Information Eli Lilly FDA Drug Label Saxenda (liraglutide) Prescribing Information Novo Nordisk FDA Drug Label Limitations This is not dosing advice

Remarkably, the survival benefits of GLP-1RAs, as observed in CVOTs, typically manifest over a more extended period than what our Kaplan Meier curves suggest 15,33

Boxed warnings apply to certain medications that carry serious risks for the person taking them

This is exactly why physician supervision and personalized nutritional guidance are not optional add-ons

This is why some clinicians advocate for faster dose escalation in higher-weight individuals and slower escalation for those closer to goal weight